Skip to main content

Sernova Biotherapeutics

corporate_fare Company Profile

Sernova Biotherapeutics

SEOVF·OTC·Life Sciences·CIK 0001491434

Sernova Biotherapeutics Inc is a clinical-stage biotechnology company based in Mississauga, Canada. The company focuses on developing regenerative medicine therapeutics. Its primary offering is the proprietary Cell Pouch, which is a bio-hybrid organ system designed to replicate natural body functions. The Cell Pouch creates vascularized organs to support the longevity and functionality of therapeutic cells, while also ensuring containment for retrievability. The company was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025.

Sernova Biotherapeutics (OTC:SEOVF) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for SEOVF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 8/10. Across its 3 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above.

Recent high-impact activity:

  • Sernova and Seraxis Merge to Form BetaNova, Targeting Type 1 Diabetes Cell Therapy
  • Sernova's Autologous Islet Transplant Therapy Gets FDA Orphan Drug Designation
  • Sernova Secures $7.1M in Financing, Plans to Retire $17M Debt to Strengthen Balance Sheet
$0.1014 -0.00% today
52-week range · as of 2026-09-08 $0.0651 – $0.1567
Market cap
$38.29M
Volume
346.5K (3.8× avg)
3-mo avg 90.4K
Live data · 2026-09-14 01:24 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SEOVF - Latest Insights

SEOVF
Sep 08, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Sernova and Seraxis Merge to Form BetaNova, Targeting Type 1 Diabetes Cell Therapy
Price at Filing: $0.0812
Real-time Price: $0.1014 info
Change: +$0.0202 (+25%) info
Market Cap: $38.293M info
Sentiment: Positive
View Wiseek Article
SEOVF
Jun 17, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Sernova's Autologous Islet Transplant Therapy Gets FDA Orphan Drug Designation
Price at Filing: $0.10546
Real-time Price: $0.1014 info
Change: -$0.00406 (-4%) info
Market Cap: $38.293M info
Sentiment: Positive
View Wiseek Article
SEOVF
Mar 04, 2026, 7:00 AM EST
Source: TMX Newsfile
Importance Score:
8
Sernova Secures $7.1M in Financing, Plans to Retire $17M Debt to Strengthen Balance Sheet
Price at Filing: $0.1029
Real-time Price: $0.1014 info
Change: -$0.0015 (-1%) info
Market Cap: $38.293M info
Sentiment: Positive
View Wiseek Article
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets